CANADA LIFE ASSURANCE Co cut its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,706,843 shares of the company's stock after selling 155,297 shares during the period. CANADA LIFE ASSURANCE Co owned about 0.31% of UiPath worth $21,659,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Jackson Creek Investment Advisors LLC bought a new stake in UiPath in the 4th quarter valued at $298,000. Principal Financial Group Inc. increased its stake in UiPath by 10.5% in the third quarter. Principal Financial Group Inc. now owns 36,685 shares of the company's stock valued at $470,000 after acquiring an additional 3,477 shares during the period. ING Groep NV bought a new stake in UiPath in the fourth quarter valued at about $3,120,000. Pacer Advisors Inc. raised its position in UiPath by 698.1% in the fourth quarter. Pacer Advisors Inc. now owns 289,471 shares of the company's stock worth $3,679,000 after purchasing an additional 253,203 shares in the last quarter. Finally, Savant Capital LLC lifted its stake in UiPath by 483.1% during the fourth quarter. Savant Capital LLC now owns 225,906 shares of the company's stock worth $2,871,000 after purchasing an additional 187,161 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
PATH has been the subject of a number of recent research reports. Canaccord Genuity Group dropped their target price on UiPath from $19.00 to $14.00 and set a "buy" rating for the company in a report on Thursday, March 13th. BMO Capital Markets dropped their price objective on UiPath from $16.00 to $11.50 and set a "market perform" rating for the company in a research note on Friday, March 14th. Mizuho reduced their target price on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Scotiabank dropped their target price on shares of UiPath from $15.00 to $12.00 and set a "sector perform" rating for the company in a research report on Thursday, March 13th. Finally, Wells Fargo & Company reduced their price target on shares of UiPath from $13.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $12.72.
View Our Latest Stock Report on UiPath
UiPath Stock Up 3.9 %
PATH traded up $0.42 during trading on Thursday, hitting $11.29. The company had a trading volume of 16,320,037 shares, compared to its average volume of 10,588,756. The company has a market capitalization of $6.23 billion, a PE ratio of -70.56 and a beta of 1.04. UiPath Inc. has a one year low of $9.38 and a one year high of $20.95. The firm's 50-day moving average price is $11.40 and its 200 day moving average price is $12.76.
Insider Buying and Selling at UiPath
In other news, CAO Hitesh Ramani sold 12,500 shares of the firm's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the completion of the transaction, the chief accounting officer now owns 314,891 shares in the company, valued at $3,208,739.29. This trade represents a 3.82 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 22.37% of the company's stock.
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.